← back to search

Catherine J. Wu

Dana-Farber/Harvard Cancer Center · US
Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
h-index
98
citations
62,378
works
1,280
NIH funding
primary concept
email

Recent publications

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
Nature 2025cited by 153position: middledoi
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy
Cell 2025cited by 49position: middledoi
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
Cancer Discovery 2025cited by 28position: middledoi
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Journal of Hematology & Oncology 2025cited by 27position: middledoi
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma
Cancer Cell 2025cited by 26position: middledoi
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Science Immunology 2025cited by 25position: middledoi
Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies
Leukemia 2025cited by 6position: middledoi
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Nature Communications 2025cited by 5position: middledoi
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Blood 2025cited by 3position: lastdoi
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination
Nature Nanotechnology 2024cited by 151position: middledoi
Immune responses in checkpoint myocarditis across heart, blood and tumour
Nature 2024cited by 53position: middledoi
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses
Nature Biotechnology 2024cited by 49position: middledoi
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Nature Communications 2024cited by 32position: lastdoi
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice
Journal of Clinical Investigation 2024cited by 18position: middledoi
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Nature Biotechnology 2024cited by 16position: lastdoi
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Leukemia 2024cited by 13position: middledoi
CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness
Science Advances 2024cited by 9position: middledoi
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Blood Cancer Discovery 2024cited by 7position: lastdoi
T cell activation contributes to purifying selection against the MELAS‐associated m.3243A>G pathogenic variant in blood
Journal of Inherited Metabolic Disease 2024cited by 6position: middledoi
Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling
Med 2024cited by 3position: middledoi
Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons
ACS Central Science 2024cited by 3position: middledoi
Dynamics and specificities of T cells in cancer immunotherapy
Nature reviews. Cancer 2023cited by 490position: lastdoi
Dictionary of immune responses to cytokines at single-cell resolution
Nature 2023cited by 323position: middledoi
Slide-tags enables single-nucleus barcoding for multimodal spatial genomics
Nature 2023cited by 190position: middledoi
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Science Immunology 2023cited by 113position: middledoi
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Nature Medicine 2023cited by 81position: lastdoi
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Blood 2023cited by 50position: lastdoi
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
Journal of Clinical Investigation 2023cited by 41position: middledoi
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Nature Cancer 2023cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Donna Neuberg · Massachusetts General Hospital26 papers (2012–2024)Gad Getz · Broad Institute17 papers (2013–2024)Nir Hacohen · Broad Institute16 papers (2012–2023)Kenneth J. Livak · Broad Institute13 papers (2014–2025)Derin B. Keskin · Harvard University12 papers (2014–2024)Satyen H. Gohil · Royal London Hospital10 papers (2020–2024)Livius Penter · German Cancer Research Center10 papers (2021–2025)Sachet A. Shukla · The University of Texas MD Anderson Cancer Center9 papers (2014–2018)Dan A. Landau · Yonsei University9 papers (2013–2020)Jennifer R. Brown · Harvard University9 papers (2012–2021)Daniel Rosebrock · Max Planck Institute for Molecular Genetics7 papers (2015–2023)Jerome Ritz · Harvard University7 papers (2014–2025)Kirsten Fischer · Ludwig-Maximilians-Universität München6 papers (2014–2021)Matthew S. Davids · Harvard University6 papers (2019–2025)J. Bryan Iorgulescu · Broad Institute6 papers (2019–2023)Robert J. Soiffer · Harvard University6 papers (2020–2025)Michael Hallek · Max Planck Institute for the Study of Societies6 papers (2014–2021)Amaro Taylor‐Weiner · Critical Path Institute6 papers (2014–2020)Carrie Sougnez · Broad Institute6 papers (2013–2015)Wandi Zhang · Shandong University6 papers (2017–2021)